Fulminant Hepatic Failure as the Initial Manifestation of Small-Cell Lung Cancer: Report of 2 Cases
-
- Terashima Takeshi
- Department of Internal Medicine, Tokyo Dental College Ichikawa General Hospital
-
- Matsuzaki Tatsu
- Department of Internal Medicine, Tokyo Dental College Ichikawa General Hospital
-
- Ogawa Rika
- Department of Internal Medicine, Tokyo Dental College Ichikawa General Hospital
-
- Naitou Asuka
- Department of Internal Medicine, Tokyo Dental College Ichikawa General Hospital
-
- Inokuchi Sayaka
- Department of Gastroenterology, Tokyo Dental College Ichikawa General Hospital
-
- Kaida Shogo
- Department of Gastroenterology, Tokyo Dental College Ichikawa General Hospital
-
- Kishikawa Hiroshi
- Department of Gastroenterology, Tokyo Dental College Ichikawa General Hospital
-
- Nishida Jiro
- Department of Gastroenterology, Tokyo Dental College Ichikawa General Hospital
-
- Tanaka Yoichi
- Department of Clinical Pathology, Tokyo Dental College Ichikawa General Hospital
-
- Miyauchi Jun
- Department of Clinical Pathology, Tokyo Dental College Ichikawa General Hospital
-
- Morishita Tetsuo
- Department of Internal Medicine, Tokyo Dental College Ichikawa General Hospital
-
- Ishizaka Akitoshi
- Department of Internal Medicine, Keio University, School of Medicine
この論文をさがす
抄録
In this report, we describe two cases of small-cell lung cancer (SCLC) presenting with fulminant hepatic failure as the initial manifestation. Neither of the patients had a previous history of liver disease, evidence of viral infection, or exposure to hepatotoxins. Both presented with hepatomegaly and an increase in the serum LDH level. Although they had a history of smoking and respiratory symptoms such as dyspnea on exertion, their most striking initial symptoms were those of hepatic failure, which made it difficult to suspect the underlying primary lung cancer. In one case, contrast-enhanced CT of the abdomen revealed hypovascular nodules that were not visible on plain CT. After a rapidly deteriorating course, both patients died, 8 and 13 days after admission, respectively. Autopsy revealed diffuse infiltration of the hepatic sinusoids and extensive replacement of the liver parenchyma by metastatic small-cell carcinoma. We conclude that metastatic SCLC should be considered in the differential diagnosis in patients of advanced age with a smoking history presenting with rapidly progressive liver failure associated with hepatomegaly and elevation of the serum LDH.
収録刊行物
-
- Annals of Cancer Research and Therapy
-
Annals of Cancer Research and Therapy 16 (1), 16-20, 2008
日本癌病態治療研究会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001205188631680
-
- NII論文ID
- 130000119344
-
- ISSN
- 18805469
- 13446835
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可